Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
US8450272B2 · kind B2 · utility
3Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 7, 2007 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Oct 5, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/655
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combination of two or more Somatostatin (SRIF) peptidomimetics (also referred to as Somatostatin- or SRIF-analogs) which have different selectivity for the five human somatostatin receptor subtypes, the use of such combination in the treatment of a disease mediated by activation of somatostatin receptors, and to pharmaceutical compositions comprising such a combination.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.